June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Activation of EPAC1-Rap1 Prevents and Reverses VEGF Induced Endothelial Permeability
Author Affiliations & Notes
  • Carla Jhoana Ramos
    University of Michigan, Ann Arbor, MI
  • David Antonetti
    University of Michigan, Ann Arbor, MI
  • Footnotes
    Commercial Relationships Carla Jhoana Ramos, None; David Antonetti, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2270. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Carla Jhoana Ramos, David Antonetti; Activation of EPAC1-Rap1 Prevents and Reverses VEGF Induced Endothelial Permeability . Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2270.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Purpose: Activation of Rap1 through the cAMP-dependent guanine nucleotide exchange factor EPAC1 was reported to enhance barrier function in human umbilical endothelial cells through rasip1 regulation of Rho activation. However, the role of EPAC1 in retinal endothelial barrier and the relationship to vascular endothelial growth factor (VEGF) induced permeability is unknown. We hypothesize that EPAC1 activation inhibits VEGF-induced permeability in retinal endothelial cells.

Methods: Methods: Primary, bovine retinal endothelial cells (BREC) were used to model the blood retinal barrier. The cAMP analog 8-pCPT-2-O-Me-cAMP-AM (8CPT) was used to specifically activate EPAC1. Cell monolayer permeability was measured by electrical resistance using the ECIS-ZΘ system or by measuring 70kDa RITC dextran flux across transwell filters. Rap1A activation was determined using a Rap capture assay with GST-RalGDS to capture active Rap1A followed by Western blot. RhoA activity was measured using Rho GTP binding protein ELISA assay.

Results: Results: Western blot of BREC lysates revealed the presence of EPAC1, Rap1A, and rasip1. Treatment of BREC monolayers with VEGF increased permeability to 70kDa dextran (p<0.0001) and reduced electrical resistance (p<0.0001). Pre-treatment of BREC with 8CPT completely prevented both the VEGF-induced permeability to dextran (p<0.0001) and the reduction in electrical resistance (p<0.0001). Importantly, treatment of BREC with VEGF followed by 8CPT treatment reversed VEGF-induced permeability to solute and ion flux. Compared to control and VEGF treatments, 8CPT and 8CPT+VEGF treatments revealed an increase in Rap1A activation (p<0.001) as well as an increase in rasip1 and Rap1A co-immunoprecipitation. Immunocytochemistry revealed that tight junctional proteins ZO-1, occludin, and claudin-5 were disrupted in cells treated with VEGF and protected in cells treated with 8CPT prior to VEGF treatment.

Conclusions: Conclusions: These data demonstrate that activation of Rap1A in retinal endothelial cells through the cAMP dependent guanine nucleotide exchange factor EPAC1 promotes barrier properties and inhibits VEGF-induced permeability. Importantly, Rap1 activation reversed VEGF induced permeability. Collectively, these data suggest activation of Rap1 may provide a therapeutic means to restore barrier properties in diseases of increased retinal permeability.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.